glp-1 jardiance is a glp 1 inhibitor Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study Is Jardiance (empagliflozin) a sodium‑glucose
Description
In order to use sugar for energy, insulin helps move it from the blood to other tissues of the body
Glucocorticoids suppress GLP-1 secretion: possible contribution to their diabetogenic effects
Microbes and inflammation in colorectal cancer
Clients with Type 1 Diabetes, pregnant or nursing or have/had thyroid cancer are NOT candidates for Semaglutide
Interestingly, in ex vivo studies from human tissue, the duodenum and ileum but not the colon were found to be glucose responsive (218) which is different than what is reported in mouse colon (178, 191) but are consistent with data where patients that have had colon resection have normal GLP-1 responses to glucose (185)
This risk appears to increase with treatment duration beyond 1.5 years
